Picture of Geneuro SA logo

GNRO — Geneuro SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: GeNeuro Q1 2018 Operating Revenues Up at 2.9 Million Euros

May 9 (Reuters) - GENEURO SA  GNRO.PA :
    * Q1 2018 OPERATING REVENUES OF EUR 2.9 MILLION (+ 84%
VERSUS. Q1
2017)
    * EUR 20.0 MILLION CASH AT MARCH 31, 2018
    * GENEURO CONTINUED ITS DEVELOPMENTS IN TYPE 1 DIABETES AND
AMYOTROPHIC LATERAL SCLEROSIS (ALS), ALSO KNOWN AS LOU GEHRIG'S
DISEASE
    * IN TYPE 1 DIABETES, PRELIMINARY RESULTS ARE EXPECTED IN Q3
OF
2018 FOR PHASE IIA TRIAL

Source text for Eikon:  ID:nBw5Cdhsfa 
Further company coverage:  GNRO.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Geneuro SA

See all news